Foghorn Therapeutics Files DEFA14A Proxy Materials
Ticker: FHTX · Form: DEFA14A · Filed: Apr 30, 2026 · CIK: 0001822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory-filing, shareholder-meeting
Related Tickers: FHTX
TL;DR
Foghorn (FHTX) filed proxy docs 4/30 - shareholder vote incoming.
AI Summary
Foghorn Therapeutics Inc. filed a Definitive Additional Materials (DEFA14A) on April 30, 2026. This filing relates to the solicitation of proxies for a special meeting of stockholders. The company is headquartered at 500 Technology Square, Suite 700, Cambridge, MA 02139.
Why It Matters
This filing indicates that Foghorn Therapeutics is actively engaging with its shareholders regarding important corporate matters, likely related to upcoming votes or proposals that could impact the company's direction.
Risk Assessment
Risk Level: low — A DEFA14A filing is a standard regulatory document for proxy solicitations and does not inherently indicate increased risk.
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Filer of the DEFA14A
- 0001822462 (company) — CIK number for Foghorn Therapeutics Inc.
- 0001193125-26-193948 (filing_id) — SEC Accession Number for the DEFA14A filing
- 2026-04-30 (date) — Filing date of the DEFA14A
- 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 (address) — Mailing and Business Address for Foghorn Therapeutics Inc.
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which stands for Additional definitive proxy soliciting materials and Rule 14(a)(12) material.
When was this filing made?
The filing date was April 30, 2026.
What is the CIK number for Foghorn Therapeutics Inc.?
The CIK number for Foghorn Therapeutics Inc. is 0001822462.
Where is Foghorn Therapeutics Inc. located?
Foghorn Therapeutics Inc. is located at 500 Technology Square, Suite 700, Cambridge, MA 02139.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001193125-26-193948.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2026 regarding Foghorn Therapeutics Inc. (FHTX).